FDA Clears Cingulate to File for Marketing Approval of
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...
Source: globenewswire.com
📰 Date Sufficient News
Date Sufficient News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Date Sufficient. Real-time updates on events, politics, business and more.
FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently ...
Source: businessinsider.com